Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Positive-Pressure Respiration | 48 | 2023 | 639 | 9.610 |
Why?
|
Respiration, Artificial | 56 | 2024 | 2630 | 5.040 |
Why?
|
Tidal Volume | 26 | 2023 | 488 | 4.410 |
Why?
|
Respiratory Mechanics | 15 | 2024 | 699 | 3.150 |
Why?
|
Lung Injury | 7 | 2023 | 422 | 3.120 |
Why?
|
Esophagus | 18 | 2021 | 1033 | 3.070 |
Why?
|
Intensive Care Units | 53 | 2024 | 3744 | 2.620 |
Why?
|
Ventilator-Induced Lung Injury | 12 | 2022 | 120 | 2.590 |
Why?
|
Acute Lung Injury | 15 | 2021 | 367 | 2.460 |
Why?
|
Critical Care | 32 | 2024 | 2697 | 2.380 |
Why?
|
Anesthetics, Inhalation | 5 | 2022 | 574 | 1.960 |
Why?
|
Respiratory Insufficiency | 15 | 2024 | 1230 | 1.910 |
Why?
|
Sepsis | 22 | 2024 | 2585 | 1.850 |
Why?
|
Manometry | 8 | 2021 | 454 | 1.740 |
Why?
|
Lung | 23 | 2024 | 10002 | 1.650 |
Why?
|
Hospital Mortality | 33 | 2024 | 5293 | 1.510 |
Why?
|
Pressure | 12 | 2019 | 1154 | 1.430 |
Why?
|
Lung Compliance | 7 | 2024 | 200 | 1.350 |
Why?
|
Critical Illness | 21 | 2024 | 2723 | 1.280 |
Why?
|
Perioperative Care | 5 | 2024 | 1036 | 1.230 |
Why?
|
Shock, Septic | 8 | 2024 | 768 | 1.210 |
Why?
|
Prone Position | 6 | 2018 | 196 | 1.190 |
Why?
|
Postoperative Complications | 17 | 2024 | 15633 | 1.150 |
Why?
|
Surgical Procedures, Operative | 5 | 2018 | 1924 | 1.070 |
Why?
|
Neuromuscular Blocking Agents | 4 | 2021 | 129 | 1.040 |
Why?
|
Cardiac Surgical Procedures | 10 | 2022 | 3627 | 1.030 |
Why?
|
Neuromuscular Blockade | 5 | 2024 | 147 | 0.970 |
Why?
|
Thoracic Wall | 3 | 2018 | 202 | 0.910 |
Why?
|
Propofol | 5 | 2023 | 603 | 0.880 |
Why?
|
Methyl Ethers | 2 | 2022 | 196 | 0.840 |
Why?
|
Respiration | 3 | 2024 | 1657 | 0.750 |
Why?
|
Head Injuries, Closed | 8 | 2000 | 133 | 0.740 |
Why?
|
Thoracic Surgical Procedures | 2 | 2023 | 350 | 0.740 |
Why?
|
Cholecalciferol | 3 | 2021 | 553 | 0.730 |
Why?
|
Humans | 236 | 2024 | 761572 | 0.730 |
Why?
|
Oxygen Inhalation Therapy | 6 | 2022 | 411 | 0.700 |
Why?
|
Vasoconstrictor Agents | 7 | 2023 | 654 | 0.690 |
Why?
|
Thorax | 1 | 2022 | 555 | 0.660 |
Why?
|
Fluid Therapy | 6 | 2023 | 579 | 0.650 |
Why?
|
Mass Casualty Incidents | 5 | 2008 | 179 | 0.630 |
Why?
|
Preoperative Care | 3 | 2018 | 2242 | 0.630 |
Why?
|
High-Frequency Ventilation | 2 | 2015 | 88 | 0.600 |
Why?
|
Anesthesia, Intravenous | 1 | 2018 | 129 | 0.600 |
Why?
|
Respiratory Function Tests | 6 | 2016 | 1682 | 0.590 |
Why?
|
Echocardiography | 8 | 2017 | 4989 | 0.590 |
Why?
|
Pulmonary Wedge Pressure | 2 | 2018 | 273 | 0.580 |
Why?
|
Natriuretic Peptides | 1 | 2018 | 155 | 0.580 |
Why?
|
Esophageal pH Monitoring | 1 | 2018 | 202 | 0.570 |
Why?
|
Triage | 8 | 2009 | 986 | 0.550 |
Why?
|
Patient Admission | 6 | 2017 | 1367 | 0.550 |
Why?
|
Thoracic Surgery | 1 | 2023 | 722 | 0.540 |
Why?
|
Ventilators, Mechanical | 6 | 2024 | 288 | 0.540 |
Why?
|
Acute Kidney Injury | 4 | 2013 | 1924 | 0.540 |
Why?
|
Out-of-Hospital Cardiac Arrest | 2 | 2018 | 339 | 0.530 |
Why?
|
Intraoperative Complications | 2 | 2024 | 1166 | 0.530 |
Why?
|
Vitamin D Deficiency | 3 | 2021 | 1388 | 0.530 |
Why?
|
Monitoring, Physiologic | 6 | 2024 | 1779 | 0.520 |
Why?
|
Brain Injuries | 4 | 2017 | 2053 | 0.520 |
Why?
|
Angiopoietin-2 | 3 | 2024 | 172 | 0.520 |
Why?
|
Male | 124 | 2024 | 360842 | 0.520 |
Why?
|
Anesthesiology | 4 | 2018 | 1120 | 0.520 |
Why?
|
Length of Stay | 14 | 2021 | 6426 | 0.500 |
Why?
|
Health Care Costs | 4 | 2024 | 3242 | 0.500 |
Why?
|
Aged | 89 | 2024 | 169310 | 0.500 |
Why?
|
Middle Aged | 96 | 2024 | 220920 | 0.500 |
Why?
|
Hemodynamics | 3 | 2017 | 4160 | 0.490 |
Why?
|
Accidents, Traffic | 5 | 2009 | 816 | 0.490 |
Why?
|
Troponin | 1 | 2018 | 502 | 0.490 |
Why?
|
Female | 121 | 2024 | 392686 | 0.480 |
Why?
|
Intracranial Pressure | 1 | 2017 | 324 | 0.480 |
Why?
|
Tissue Plasminogen Activator | 4 | 2021 | 1164 | 0.480 |
Why?
|
Pneumoperitoneum, Artificial | 1 | 2014 | 41 | 0.470 |
Why?
|
Posture | 1 | 2018 | 957 | 0.450 |
Why?
|
Severity of Illness Index | 16 | 2021 | 15843 | 0.440 |
Why?
|
Blood Loss, Surgical | 1 | 2017 | 638 | 0.440 |
Why?
|
Hypotension | 3 | 2023 | 879 | 0.430 |
Why?
|
Oliguria | 1 | 2012 | 21 | 0.430 |
Why?
|
Oxygen | 9 | 2021 | 4227 | 0.420 |
Why?
|
Hypnotics and Sedatives | 5 | 2023 | 1179 | 0.420 |
Why?
|
Randomized Controlled Trials as Topic | 14 | 2021 | 10212 | 0.420 |
Why?
|
Risk Assessment | 13 | 2018 | 23996 | 0.420 |
Why?
|
Coronary Artery Bypass | 4 | 2017 | 2188 | 0.410 |
Why?
|
Patient Preference | 2 | 2019 | 924 | 0.400 |
Why?
|
Vitamins | 2 | 2021 | 1635 | 0.400 |
Why?
|
APACHE | 5 | 2021 | 267 | 0.400 |
Why?
|
Adult | 74 | 2024 | 221203 | 0.400 |
Why?
|
Organizational Culture | 4 | 2019 | 508 | 0.390 |
Why?
|
Interleukin-8 | 2 | 2024 | 696 | 0.390 |
Why?
|
Protein C | 2 | 2009 | 133 | 0.380 |
Why?
|
Wounds and Injuries | 4 | 2013 | 2491 | 0.380 |
Why?
|
Retrospective Studies | 46 | 2024 | 80646 | 0.380 |
Why?
|
Laryngoscopy | 1 | 2017 | 707 | 0.380 |
Why?
|
Health Status Indicators | 4 | 2020 | 970 | 0.370 |
Why?
|
Postoperative Care | 1 | 2017 | 1468 | 0.370 |
Why?
|
Anesthesia, General | 6 | 2024 | 1174 | 0.370 |
Why?
|
Intubation, Intratracheal | 4 | 2022 | 1333 | 0.360 |
Why?
|
Monitoring, Intraoperative | 2 | 2017 | 942 | 0.360 |
Why?
|
Renal Replacement Therapy | 1 | 2012 | 282 | 0.350 |
Why?
|
Erythrocyte Transfusion | 2 | 2013 | 570 | 0.350 |
Why?
|
Pneumonia | 1 | 2022 | 2143 | 0.350 |
Why?
|
Lactic Acid | 3 | 2013 | 1139 | 0.350 |
Why?
|
Emergency Service, Hospital | 14 | 2020 | 7879 | 0.350 |
Why?
|
Creatinine | 2 | 2012 | 1899 | 0.340 |
Why?
|
Phenylephrine | 3 | 1999 | 293 | 0.340 |
Why?
|
Practice Guidelines as Topic | 8 | 2018 | 7391 | 0.340 |
Why?
|
Anesthetics, Intravenous | 3 | 2022 | 395 | 0.330 |
Why?
|
Anti-Ulcer Agents | 1 | 2010 | 112 | 0.330 |
Why?
|
Family | 3 | 2018 | 3194 | 0.330 |
Why?
|
Conscious Sedation | 3 | 2022 | 532 | 0.330 |
Why?
|
Quality-Adjusted Life Years | 3 | 2018 | 1722 | 0.330 |
Why?
|
von Willebrand Factor | 1 | 2013 | 673 | 0.320 |
Why?
|
Professional-Family Relations | 3 | 2019 | 495 | 0.320 |
Why?
|
Histamine H2 Antagonists | 1 | 2010 | 166 | 0.320 |
Why?
|
Terminology as Topic | 1 | 2016 | 1530 | 0.310 |
Why?
|
Atracurium | 2 | 2019 | 51 | 0.310 |
Why?
|
Influenza, Human | 3 | 2015 | 1521 | 0.300 |
Why?
|
Multiple Organ Failure | 2 | 2011 | 387 | 0.300 |
Why?
|
Safety Management | 2 | 2018 | 760 | 0.300 |
Why?
|
Stress, Physiological | 3 | 2016 | 1403 | 0.300 |
Why?
|
Communication | 3 | 2018 | 3873 | 0.300 |
Why?
|
Prospective Studies | 29 | 2023 | 54426 | 0.300 |
Why?
|
Systemic Inflammatory Response Syndrome | 3 | 2011 | 621 | 0.300 |
Why?
|
Trauma Severity Indices | 1 | 2009 | 478 | 0.300 |
Why?
|
Cerebrovascular Circulation | 2 | 2021 | 2727 | 0.300 |
Why?
|
Insulin Infusion Systems | 1 | 2009 | 217 | 0.290 |
Why?
|
Chemical Warfare | 1 | 2007 | 18 | 0.290 |
Why?
|
Central Venous Pressure | 1 | 2007 | 79 | 0.290 |
Why?
|
Trauma Centers | 1 | 2013 | 937 | 0.290 |
Why?
|
Chemical Warfare Agents | 1 | 2007 | 19 | 0.280 |
Why?
|
Chemical Terrorism | 1 | 2007 | 12 | 0.280 |
Why?
|
Stroke Volume | 5 | 2018 | 5496 | 0.280 |
Why?
|
Oxygen Consumption | 1 | 2013 | 1866 | 0.280 |
Why?
|
Pre-Eclampsia | 2 | 2016 | 1231 | 0.280 |
Why?
|
Clinical Protocols | 4 | 2017 | 1440 | 0.280 |
Why?
|
Receptors, Immunologic | 1 | 2013 | 1410 | 0.270 |
Why?
|
Ventilator Weaning | 3 | 2023 | 164 | 0.270 |
Why?
|
Nitric Oxide | 1 | 2015 | 2135 | 0.270 |
Why?
|
Hospitalization | 6 | 2015 | 10721 | 0.270 |
Why?
|
Hyperoxia | 2 | 2019 | 258 | 0.270 |
Why?
|
Cross Infection | 2 | 2019 | 1422 | 0.270 |
Why?
|
Cost-Benefit Analysis | 5 | 2018 | 5492 | 0.270 |
Why?
|
Brain Edema | 7 | 2000 | 604 | 0.260 |
Why?
|
Influenza A Virus, H5N1 Subtype | 1 | 2007 | 113 | 0.260 |
Why?
|
Postoperative Period | 5 | 2021 | 1814 | 0.260 |
Why?
|
Durable Medical Equipment | 1 | 2006 | 23 | 0.260 |
Why?
|
Cerebral Hemorrhage | 3 | 2017 | 2656 | 0.260 |
Why?
|
Pandemics | 5 | 2021 | 8656 | 0.260 |
Why?
|
Blood Glucose | 4 | 2017 | 6391 | 0.260 |
Why?
|
Pulmonary Gas Exchange | 3 | 2019 | 379 | 0.250 |
Why?
|
Cause of Death | 4 | 2017 | 3683 | 0.250 |
Why?
|
Abscess | 1 | 2009 | 606 | 0.250 |
Why?
|
Prognosis | 17 | 2021 | 29629 | 0.250 |
Why?
|
Extracorporeal Membrane Oxygenation | 2 | 2017 | 1462 | 0.250 |
Why?
|
Risk Factors | 29 | 2021 | 74213 | 0.250 |
Why?
|
Hospitals | 3 | 2021 | 3882 | 0.250 |
Why?
|
Proton Pump Inhibitors | 1 | 2010 | 532 | 0.240 |
Why?
|
Cardiopulmonary Bypass | 3 | 2019 | 1092 | 0.240 |
Why?
|
Cardiomyopathies | 2 | 2016 | 1964 | 0.240 |
Why?
|
Health Resources | 3 | 2017 | 935 | 0.240 |
Why?
|
Aged, 80 and over | 25 | 2021 | 58986 | 0.240 |
Why?
|
Multivariate Analysis | 10 | 2017 | 12059 | 0.240 |
Why?
|
Insulin | 2 | 2009 | 6597 | 0.230 |
Why?
|
Registries | 3 | 2024 | 8224 | 0.230 |
Why?
|
Treatment Outcome | 26 | 2023 | 64684 | 0.230 |
Why?
|
Vascular Surgical Procedures | 2 | 2011 | 1489 | 0.220 |
Why?
|
Judgment | 1 | 2006 | 273 | 0.220 |
Why?
|
Delirium | 3 | 2021 | 1668 | 0.220 |
Why?
|
Aspirin | 4 | 2023 | 3133 | 0.220 |
Why?
|
Clostridium Infections | 1 | 2010 | 558 | 0.210 |
Why?
|
Craniocerebral Trauma | 2 | 2006 | 490 | 0.210 |
Why?
|
Boston | 10 | 2021 | 9326 | 0.210 |
Why?
|
Neurotoxicity Syndromes | 1 | 2007 | 301 | 0.210 |
Why?
|
Time Factors | 21 | 2023 | 39970 | 0.210 |
Why?
|
Phenotype | 1 | 2021 | 16592 | 0.210 |
Why?
|
Airway Obstruction | 1 | 2008 | 661 | 0.210 |
Why?
|
Consensus | 3 | 2024 | 3123 | 0.210 |
Why?
|
Intracranial Embolism | 1 | 2004 | 189 | 0.200 |
Why?
|
Attitude of Health Personnel | 5 | 2019 | 3889 | 0.200 |
Why?
|
Hypoglycemia | 1 | 2009 | 883 | 0.190 |
Why?
|
Image Enhancement | 1 | 2012 | 2885 | 0.190 |
Why?
|
Survivors | 3 | 2021 | 2371 | 0.190 |
Why?
|
Patient Positioning | 2 | 2014 | 326 | 0.190 |
Why?
|
Heart Valve Diseases | 1 | 2009 | 1027 | 0.190 |
Why?
|
Ventricular Dysfunction, Left | 1 | 2012 | 2118 | 0.190 |
Why?
|
Survival | 1 | 2021 | 161 | 0.190 |
Why?
|
Multiple Trauma | 1 | 2004 | 369 | 0.190 |
Why?
|
Heart Ventricles | 2 | 2012 | 3807 | 0.190 |
Why?
|
Intraoperative Care | 2 | 2024 | 767 | 0.180 |
Why?
|
Pneumonia, Ventilator-Associated | 2 | 2014 | 279 | 0.180 |
Why?
|
Disease Outbreaks | 2 | 2007 | 1749 | 0.180 |
Why?
|
Capillary Permeability | 1 | 2024 | 773 | 0.180 |
Why?
|
Delphi Technique | 1 | 2024 | 846 | 0.180 |
Why?
|
Health Care Rationing | 2 | 2008 | 437 | 0.170 |
Why?
|
Water-Electrolyte Balance | 1 | 2021 | 325 | 0.170 |
Why?
|
Blood Gas Analysis | 2 | 2019 | 379 | 0.170 |
Why?
|
Supine Position | 2 | 2018 | 205 | 0.170 |
Why?
|
Respiration Disorders | 1 | 2023 | 367 | 0.170 |
Why?
|
Deep Sedation | 1 | 2021 | 118 | 0.170 |
Why?
|
Predictive Value of Tests | 11 | 2016 | 15266 | 0.170 |
Why?
|
Catheterization | 2 | 2016 | 1428 | 0.170 |
Why?
|
Troponin T | 1 | 2004 | 780 | 0.160 |
Why?
|
Treatment Failure | 3 | 2020 | 2644 | 0.160 |
Why?
|
Hospital Bed Capacity | 2 | 2014 | 206 | 0.160 |
Why?
|
Rwanda | 5 | 2021 | 665 | 0.160 |
Why?
|
Survival Rate | 6 | 2020 | 12725 | 0.160 |
Why?
|
Anti-Inflammatory Agents, Non-Steroidal | 3 | 2019 | 2273 | 0.160 |
Why?
|
Sodium Chloride | 3 | 2014 | 587 | 0.160 |
Why?
|
Heart Valve Prosthesis Implantation | 1 | 2009 | 1553 | 0.160 |
Why?
|
ROC Curve | 6 | 2021 | 3579 | 0.160 |
Why?
|
Point-of-Care Systems | 4 | 2017 | 1213 | 0.160 |
Why?
|
Double-Blind Method | 8 | 2021 | 12341 | 0.150 |
Why?
|
Acetaminophen | 2 | 2021 | 554 | 0.150 |
Why?
|
Coronavirus Infections | 3 | 2020 | 3086 | 0.150 |
Why?
|
JNK Mitogen-Activated Protein Kinases | 1 | 2000 | 441 | 0.150 |
Why?
|
Pneumonia, Viral | 3 | 2020 | 3206 | 0.150 |
Why?
|
Health Personnel | 3 | 2019 | 3335 | 0.150 |
Why?
|
Diuretics | 1 | 2021 | 610 | 0.150 |
Why?
|
Logistic Models | 11 | 2017 | 13255 | 0.150 |
Why?
|
Decision Support Techniques | 2 | 2020 | 1998 | 0.150 |
Why?
|
Emergency Medical Services | 2 | 2008 | 1923 | 0.150 |
Why?
|
Anesthesia Recovery Period | 1 | 2018 | 155 | 0.150 |
Why?
|
Dissent and Disputes | 1 | 2019 | 146 | 0.150 |
Why?
|
Cohort Studies | 15 | 2024 | 41493 | 0.150 |
Why?
|
Blood Platelet Disorders | 1 | 2018 | 60 | 0.150 |
Why?
|
United States | 23 | 2020 | 72335 | 0.150 |
Why?
|
Survival Analysis | 8 | 2019 | 10090 | 0.140 |
Why?
|
Operating Rooms | 1 | 2024 | 789 | 0.140 |
Why?
|
Exhalation | 1 | 2018 | 181 | 0.140 |
Why?
|
Health Services Misuse | 1 | 2019 | 244 | 0.140 |
Why?
|
Intention | 1 | 2019 | 347 | 0.140 |
Why?
|
Fibrinolytic Agents | 3 | 2021 | 2084 | 0.140 |
Why?
|
Hydroxychloroquine | 1 | 2020 | 426 | 0.140 |
Why?
|
Early Ambulation | 1 | 2016 | 49 | 0.130 |
Why?
|
Drug Resistance, Microbial | 1 | 2019 | 825 | 0.130 |
Why?
|
Cross-Over Studies | 1 | 2022 | 2079 | 0.130 |
Why?
|
Odds Ratio | 5 | 2017 | 9646 | 0.130 |
Why?
|
Kaplan-Meier Estimate | 3 | 2019 | 6484 | 0.130 |
Why?
|
Inhalation | 1 | 2016 | 143 | 0.130 |
Why?
|
Angiogenic Proteins | 1 | 2016 | 101 | 0.130 |
Why?
|
Shock | 1 | 2018 | 314 | 0.130 |
Why?
|
Analgesics, Non-Narcotic | 1 | 2019 | 370 | 0.130 |
Why?
|
Adrenergic beta-Agonists | 1 | 2017 | 345 | 0.130 |
Why?
|
Self-Assessment | 1 | 2018 | 397 | 0.130 |
Why?
|
Myxoma | 1 | 1996 | 114 | 0.130 |
Why?
|
Lung Diseases | 2 | 2016 | 1909 | 0.130 |
Why?
|
Respiratory Dead Space | 1 | 2015 | 31 | 0.130 |
Why?
|
Developing Countries | 5 | 2024 | 2885 | 0.130 |
Why?
|
Demography | 3 | 2016 | 1648 | 0.120 |
Why?
|
Mitogen-Activated Protein Kinases | 1 | 2000 | 1246 | 0.120 |
Why?
|
Bradycardia | 1 | 2017 | 299 | 0.120 |
Why?
|
Heart Valves | 1 | 2017 | 284 | 0.120 |
Why?
|
Respiratory Rate | 1 | 2016 | 176 | 0.120 |
Why?
|
Follow-Up Studies | 10 | 2021 | 39107 | 0.120 |
Why?
|
Resuscitation Orders | 1 | 2017 | 270 | 0.120 |
Why?
|
Drug Resistance, Multiple, Bacterial | 1 | 2019 | 587 | 0.120 |
Why?
|
Expert Testimony | 1 | 2017 | 364 | 0.120 |
Why?
|
Unnecessary Procedures | 1 | 2018 | 415 | 0.120 |
Why?
|
Infusions, Intravenous | 4 | 2021 | 2218 | 0.120 |
Why?
|
Dexmedetomidine | 1 | 2019 | 319 | 0.120 |
Why?
|
Anesthesia Department, Hospital | 1 | 2014 | 69 | 0.120 |
Why?
|
Evidence-Based Practice | 1 | 2018 | 495 | 0.110 |
Why?
|
Blood Transfusion | 2 | 2018 | 1301 | 0.110 |
Why?
|
Pneumothorax | 1 | 2017 | 386 | 0.110 |
Why?
|
Lung Volume Measurements | 1 | 2014 | 375 | 0.110 |
Why?
|
Cognition | 3 | 2021 | 6992 | 0.110 |
Why?
|
Intubation | 1 | 2013 | 139 | 0.110 |
Why?
|
Salvage Therapy | 1 | 2020 | 1264 | 0.110 |
Why?
|
Ultrasonography, Doppler | 1 | 2015 | 462 | 0.110 |
Why?
|
Comparative Effectiveness Research | 1 | 2018 | 709 | 0.110 |
Why?
|
Longitudinal Studies | 4 | 2021 | 14607 | 0.110 |
Why?
|
Glasgow Coma Scale | 2 | 2013 | 580 | 0.110 |
Why?
|
Cost Savings | 1 | 2018 | 913 | 0.110 |
Why?
|
Rewarming | 1 | 2013 | 64 | 0.110 |
Why?
|
Isoflurane | 1 | 2016 | 384 | 0.110 |
Why?
|
Blood Pressure | 4 | 2007 | 8481 | 0.110 |
Why?
|
Professional-Patient Relations | 1 | 2018 | 726 | 0.110 |
Why?
|
Physical Therapy Modalities | 1 | 2016 | 532 | 0.100 |
Why?
|
Propensity Score | 3 | 2024 | 1913 | 0.100 |
Why?
|
Massachusetts | 4 | 2024 | 8830 | 0.100 |
Why?
|
Humidity | 1 | 2013 | 205 | 0.100 |
Why?
|
Heart Neoplasms | 1 | 1996 | 362 | 0.100 |
Why?
|
Infection Control | 2 | 2018 | 982 | 0.100 |
Why?
|
Probability | 4 | 2016 | 2477 | 0.100 |
Why?
|
Reproducibility of Results | 8 | 2016 | 20099 | 0.100 |
Why?
|
Shock, Cardiogenic | 2 | 2015 | 709 | 0.100 |
Why?
|
Cytokines | 1 | 2007 | 7396 | 0.100 |
Why?
|
Research | 1 | 2021 | 1982 | 0.100 |
Why?
|
Empirical Research | 1 | 2012 | 120 | 0.100 |
Why?
|
Echocardiography, Transesophageal | 3 | 2013 | 1086 | 0.100 |
Why?
|
Young Adult | 10 | 2021 | 59255 | 0.100 |
Why?
|
Catheterization, Central Venous | 1 | 2017 | 526 | 0.100 |
Why?
|
Hypothermia, Induced | 2 | 2013 | 753 | 0.100 |
Why?
|
Executive Function | 1 | 2021 | 1392 | 0.100 |
Why?
|
Matrix Metalloproteinase 9 | 1 | 2015 | 632 | 0.100 |
Why?
|
Liver Failure | 1 | 2014 | 250 | 0.100 |
Why?
|
Cardiac Output | 1 | 2014 | 831 | 0.100 |
Why?
|
Influenza A Virus, H1N1 Subtype | 1 | 2015 | 445 | 0.100 |
Why?
|
Incidence | 9 | 2019 | 21355 | 0.100 |
Why?
|
Video Recording | 1 | 2017 | 967 | 0.100 |
Why?
|
Ascites | 1 | 2013 | 338 | 0.100 |
Why?
|
Wound Infection | 1 | 2014 | 246 | 0.100 |
Why?
|
Disaster Planning | 2 | 2008 | 557 | 0.090 |
Why?
|
Thrombolytic Therapy | 1 | 2020 | 2064 | 0.090 |
Why?
|
Academic Medical Centers | 6 | 2018 | 2759 | 0.090 |
Why?
|
Artificial Intelligence | 2 | 2023 | 2578 | 0.090 |
Why?
|
Anti-Bacterial Agents | 2 | 2019 | 7407 | 0.090 |
Why?
|
Blood Pressure Determination | 2 | 2013 | 633 | 0.090 |
Why?
|
Bacterial Infections | 1 | 2019 | 1391 | 0.090 |
Why?
|
Specific Gravity | 3 | 1999 | 18 | 0.090 |
Why?
|
Patient Care Planning | 1 | 2016 | 909 | 0.090 |
Why?
|
Students, Medical | 1 | 2024 | 1936 | 0.090 |
Why?
|
Jews | 1 | 2012 | 356 | 0.090 |
Why?
|
Research Design | 5 | 2020 | 6180 | 0.090 |
Why?
|
Tumor Necrosis Factor-alpha | 1 | 2022 | 4352 | 0.090 |
Why?
|
Gene Expression Regulation, Enzymologic | 1 | 2015 | 1171 | 0.090 |
Why?
|
Multicenter Studies as Topic | 2 | 2021 | 1702 | 0.090 |
Why?
|
Brain Diseases | 1 | 1999 | 1545 | 0.090 |
Why?
|
Arabs | 1 | 2012 | 187 | 0.090 |
Why?
|
Hypertension, Pregnancy-Induced | 1 | 2016 | 518 | 0.090 |
Why?
|
Pharmaceutical Vehicles | 1 | 2009 | 57 | 0.090 |
Why?
|
Urodynamics | 1 | 2011 | 346 | 0.090 |
Why?
|
Hernia, Ventral | 1 | 2013 | 218 | 0.080 |
Why?
|
Matched-Pair Analysis | 1 | 2010 | 284 | 0.080 |
Why?
|
Cardiopulmonary Resuscitation | 3 | 2013 | 993 | 0.080 |
Why?
|
Compliance | 1 | 2009 | 100 | 0.080 |
Why?
|
Pleural Cavity | 1 | 2009 | 25 | 0.080 |
Why?
|
Area Under Curve | 3 | 2010 | 1638 | 0.080 |
Why?
|
New England | 2 | 2023 | 1054 | 0.080 |
Why?
|
Leg | 1 | 2014 | 1088 | 0.080 |
Why?
|
Chi-Square Distribution | 5 | 2017 | 3416 | 0.080 |
Why?
|
Decision Support Systems, Clinical | 1 | 2018 | 1175 | 0.080 |
Why?
|
Glucose | 2 | 1998 | 4346 | 0.080 |
Why?
|
Subarachnoid Hemorrhage | 1 | 2017 | 1033 | 0.080 |
Why?
|
Vitamin D | 2 | 2020 | 3303 | 0.080 |
Why?
|
Hydrogen-Ion Concentration | 2 | 2008 | 2496 | 0.080 |
Why?
|
Ultrasonography, Interventional | 1 | 2017 | 1496 | 0.080 |
Why?
|
Reference Values | 1 | 2016 | 4920 | 0.080 |
Why?
|
Platelet Aggregation Inhibitors | 2 | 2011 | 2751 | 0.080 |
Why?
|
Analysis of Variance | 3 | 2006 | 6228 | 0.080 |
Why?
|
Statistics as Topic | 1 | 2015 | 2358 | 0.080 |
Why?
|
Hypertension | 2 | 1999 | 8540 | 0.080 |
Why?
|
Clinical Competence | 1 | 2024 | 4793 | 0.080 |
Why?
|
Emergency Treatment | 3 | 2007 | 496 | 0.080 |
Why?
|
Rats, Sprague-Dawley | 8 | 2000 | 8181 | 0.080 |
Why?
|
Adolescent | 8 | 2021 | 88324 | 0.080 |
Why?
|
Patient-Centered Care | 1 | 2018 | 1421 | 0.080 |
Why?
|
Adrenal Cortex Hormones | 1 | 2017 | 1881 | 0.070 |
Why?
|
Schools, Medical | 1 | 2014 | 879 | 0.070 |
Why?
|
Respiratory Protective Devices | 1 | 2008 | 47 | 0.070 |
Why?
|
Education, Continuing | 1 | 2008 | 114 | 0.070 |
Why?
|
Evidence-Based Medicine | 3 | 2015 | 3688 | 0.070 |
Why?
|
Thrombosis | 1 | 2021 | 2942 | 0.070 |
Why?
|
Climate | 1 | 2008 | 147 | 0.070 |
Why?
|
Recombinant Proteins | 2 | 2009 | 6534 | 0.070 |
Why?
|
Hemorrhage | 1 | 1999 | 3424 | 0.070 |
Why?
|
Hypovolemia | 1 | 2007 | 48 | 0.070 |
Why?
|
Dose-Response Relationship, Drug | 2 | 2010 | 10766 | 0.070 |
Why?
|
Patient Care Team | 1 | 2018 | 2521 | 0.070 |
Why?
|
Pilot Projects | 2 | 2012 | 8633 | 0.070 |
Why?
|
Intraoperative Period | 2 | 2016 | 510 | 0.070 |
Why?
|
Myocardium | 1 | 2000 | 4725 | 0.070 |
Why?
|
Oximetry | 2 | 2021 | 459 | 0.070 |
Why?
|
Lactates | 1 | 2008 | 405 | 0.070 |
Why?
|
Animals | 15 | 2018 | 168467 | 0.070 |
Why?
|
Resuscitation | 2 | 2024 | 673 | 0.070 |
Why?
|
Hypothermia | 1 | 2008 | 188 | 0.070 |
Why?
|
Maximum Tolerated Dose | 1 | 2009 | 883 | 0.070 |
Why?
|
Hospitals, University | 3 | 2019 | 564 | 0.070 |
Why?
|
Rats | 9 | 2000 | 23741 | 0.070 |
Why?
|
Swine | 1 | 2016 | 5915 | 0.070 |
Why?
|
Pulmonary Ventilation | 1 | 2008 | 372 | 0.070 |
Why?
|
Seat Belts | 1 | 2006 | 60 | 0.070 |
Why?
|
Inflammation | 2 | 2024 | 10773 | 0.070 |
Why?
|
Dinoprostone | 2 | 2000 | 597 | 0.070 |
Why?
|
Age Factors | 5 | 2018 | 18398 | 0.060 |
Why?
|
Sensitivity and Specificity | 6 | 2016 | 14666 | 0.060 |
Why?
|
Fever | 1 | 2013 | 1618 | 0.060 |
Why?
|
Sex Factors | 3 | 2024 | 10553 | 0.060 |
Why?
|
Risk Management | 1 | 2009 | 558 | 0.060 |
Why?
|
Stomach | 1 | 2009 | 696 | 0.060 |
Why?
|
Accreditation | 1 | 2008 | 473 | 0.060 |
Why?
|
Europe | 3 | 2019 | 3422 | 0.060 |
Why?
|
Health Planning Guidelines | 1 | 2005 | 151 | 0.060 |
Why?
|
Glomerular Filtration Rate | 1 | 2013 | 2177 | 0.060 |
Why?
|
Bioterrorism | 1 | 2005 | 144 | 0.060 |
Why?
|
Catheterization, Peripheral | 2 | 2013 | 343 | 0.060 |
Why?
|
Quality of Life | 2 | 2018 | 13367 | 0.060 |
Why?
|
Hospitals, Urban | 3 | 2015 | 500 | 0.060 |
Why?
|
Pulmonary Edema | 1 | 2007 | 409 | 0.060 |
Why?
|
Israel | 3 | 2012 | 726 | 0.060 |
Why?
|
Heart Rate | 3 | 2017 | 4195 | 0.060 |
Why?
|
Decision Making | 1 | 2018 | 3929 | 0.060 |
Why?
|
Disease Susceptibility | 1 | 2011 | 1787 | 0.060 |
Why?
|
Comorbidity | 5 | 2012 | 10508 | 0.060 |
Why?
|
Quality Indicators, Health Care | 1 | 2014 | 1792 | 0.060 |
Why?
|
Case-Control Studies | 3 | 2016 | 22176 | 0.060 |
Why?
|
Anesthesia | 2 | 2024 | 1595 | 0.060 |
Why?
|
Urban Population | 2 | 2014 | 2036 | 0.060 |
Why?
|
Liver Cirrhosis | 1 | 2014 | 1935 | 0.060 |
Why?
|
Bayes Theorem | 2 | 2022 | 2330 | 0.060 |
Why?
|
Quality of Health Care | 2 | 2017 | 4330 | 0.050 |
Why?
|
Urinary Bladder | 1 | 2009 | 1152 | 0.050 |
Why?
|
Reoperation | 1 | 2014 | 4303 | 0.050 |
Why?
|
Electrocardiography | 3 | 2018 | 6377 | 0.050 |
Why?
|
Cardiovascular Diseases | 1 | 2009 | 15501 | 0.050 |
Why?
|
Body Water | 3 | 2000 | 340 | 0.050 |
Why?
|
Heart Arrest | 1 | 2013 | 1514 | 0.050 |
Why?
|
Death | 2 | 2024 | 676 | 0.050 |
Why?
|
Biomedical Research | 2 | 2017 | 3429 | 0.050 |
Why?
|
Mental Recall | 2 | 2021 | 1221 | 0.050 |
Why?
|
Subclavian Vein | 1 | 2002 | 57 | 0.050 |
Why?
|
Laparoscopy | 1 | 2014 | 2036 | 0.050 |
Why?
|
Thoracic Injuries | 1 | 2005 | 288 | 0.050 |
Why?
|
Clinical Trials as Topic | 3 | 2021 | 8002 | 0.050 |
Why?
|
Patient Satisfaction | 1 | 2015 | 3461 | 0.050 |
Why?
|
Myocardial Contraction | 1 | 2007 | 1515 | 0.050 |
Why?
|
Preoperative Period | 2 | 2017 | 551 | 0.050 |
Why?
|
Stroke | 1 | 2004 | 9758 | 0.050 |
Why?
|
Ventricular Dysfunction, Right | 1 | 2007 | 628 | 0.050 |
Why?
|
Equipment Design | 1 | 2009 | 3511 | 0.050 |
Why?
|
Pulse Therapy, Drug | 1 | 2021 | 37 | 0.050 |
Why?
|
Interleukin-6 | 2 | 2024 | 3208 | 0.050 |
Why?
|
Vena Cava, Superior | 1 | 2002 | 195 | 0.050 |
Why?
|
Sleep Apnea, Obstructive | 1 | 2014 | 1875 | 0.050 |
Why?
|
Heart Septal Defects, Atrial | 1 | 2004 | 451 | 0.050 |
Why?
|
Artifacts | 1 | 2009 | 1911 | 0.050 |
Why?
|
Partial Thromboplastin Time | 1 | 2021 | 204 | 0.050 |
Why?
|
Body Temperature | 2 | 2008 | 781 | 0.050 |
Why?
|
Polypharmacy | 1 | 2023 | 306 | 0.040 |
Why?
|
Health Knowledge, Attitudes, Practice | 1 | 2015 | 4016 | 0.040 |
Why?
|
Respiratory System | 1 | 2023 | 563 | 0.040 |
Why?
|
MAP Kinase Kinase 4 | 1 | 2000 | 149 | 0.040 |
Why?
|
Evaluation Studies as Topic | 2 | 2015 | 1624 | 0.040 |
Why?
|
Peroxidases | 1 | 2000 | 134 | 0.040 |
Why?
|
Health Care Surveys | 2 | 2018 | 2426 | 0.040 |
Why?
|
Statistics, Nonparametric | 3 | 2010 | 2850 | 0.040 |
Why?
|
Cerebral Infarction | 1 | 2004 | 983 | 0.040 |
Why?
|
Time | 1 | 2021 | 546 | 0.040 |
Why?
|
Lipopolysaccharides | 2 | 2015 | 2206 | 0.040 |
Why?
|
Prostaglandin-Endoperoxide Synthases | 1 | 2000 | 318 | 0.040 |
Why?
|
Mitogen-Activated Protein Kinase 3 | 1 | 2000 | 473 | 0.040 |
Why?
|
Neurologic Examination | 2 | 2000 | 916 | 0.040 |
Why?
|
International Cooperation | 1 | 2005 | 1422 | 0.040 |
Why?
|
Pleural Effusion | 1 | 2001 | 341 | 0.040 |
Why?
|
Mitogen-Activated Protein Kinase 1 | 1 | 2000 | 477 | 0.040 |
Why?
|
Natriuretic Peptide, Brain | 1 | 2007 | 1723 | 0.040 |
Why?
|
Random Allocation | 2 | 2000 | 2395 | 0.040 |
Why?
|
Diabetes Complications | 1 | 2005 | 1315 | 0.040 |
Why?
|
Respiratory Physiological Phenomena | 1 | 2019 | 189 | 0.040 |
Why?
|
Enterobacteriaceae | 1 | 2019 | 161 | 0.040 |
Why?
|
Anesthetics, Dissociative | 1 | 1998 | 80 | 0.040 |
Why?
|
Brain Chemistry | 2 | 2000 | 960 | 0.040 |
Why?
|
Cyclooxygenase Inhibitors | 1 | 2000 | 361 | 0.040 |
Why?
|
Data Interpretation, Statistical | 1 | 2008 | 2691 | 0.040 |
Why?
|
Drug Therapy, Combination | 2 | 2019 | 6312 | 0.040 |
Why?
|
Partial Pressure | 1 | 2017 | 245 | 0.040 |
Why?
|
Gram-Negative Bacteria | 1 | 2019 | 272 | 0.040 |
Why?
|
Algorithms | 2 | 2016 | 14032 | 0.040 |
Why?
|
Anti-Infective Agents | 1 | 2005 | 983 | 0.040 |
Why?
|
Propylamines | 1 | 1998 | 161 | 0.040 |
Why?
|
Patient Selection | 1 | 2009 | 4244 | 0.040 |
Why?
|
Chest Wall Oscillation | 1 | 2017 | 15 | 0.040 |
Why?
|
beta-Lactamases | 1 | 2019 | 304 | 0.040 |
Why?
|
Mitogen-Activated Protein Kinase Kinases | 1 | 2000 | 641 | 0.040 |
Why?
|
Osmolar Concentration | 1 | 1998 | 659 | 0.040 |
Why?
|
Models, Statistical | 2 | 2016 | 5079 | 0.040 |
Why?
|
Potassium | 2 | 1998 | 1311 | 0.040 |
Why?
|
p38 Mitogen-Activated Protein Kinases | 1 | 2000 | 687 | 0.030 |
Why?
|
Diagnosis, Differential | 3 | 2007 | 12975 | 0.030 |
Why?
|
Sputum | 1 | 2019 | 506 | 0.030 |
Why?
|
Forecasting | 1 | 2006 | 2928 | 0.030 |
Why?
|
Feasibility Studies | 2 | 2018 | 5247 | 0.030 |
Why?
|
Neuropsychological Tests | 2 | 2021 | 7054 | 0.030 |
Why?
|
Mortality | 2 | 2019 | 2901 | 0.030 |
Why?
|
Myocardial Reperfusion Injury | 1 | 2000 | 481 | 0.030 |
Why?
|
Markov Chains | 1 | 2020 | 966 | 0.030 |
Why?
|
Fluorobenzenes | 1 | 1998 | 179 | 0.030 |
Why?
|
Infant, Newborn | 2 | 2017 | 26198 | 0.030 |
Why?
|
Heart Failure | 2 | 2013 | 11670 | 0.030 |
Why?
|
Serum Albumin | 1 | 1999 | 672 | 0.030 |
Why?
|
Austria | 1 | 2016 | 207 | 0.030 |
Why?
|
Regression Analysis | 2 | 2018 | 6344 | 0.030 |
Why?
|
Sodium | 2 | 1998 | 1588 | 0.030 |
Why?
|
Linear Models | 1 | 2006 | 5872 | 0.030 |
Why?
|
Cross-Sectional Studies | 3 | 2021 | 26127 | 0.030 |
Why?
|
Guideline Adherence | 1 | 2006 | 2220 | 0.030 |
Why?
|
Social Perception | 1 | 2019 | 433 | 0.030 |
Why?
|
Patient Discharge | 2 | 2021 | 3443 | 0.030 |
Why?
|
Disease Progression | 4 | 2011 | 13510 | 0.030 |
Why?
|
Fentanyl | 2 | 2014 | 434 | 0.030 |
Why?
|
Isoenzymes | 1 | 2000 | 1687 | 0.030 |
Why?
|
Intention to Treat Analysis | 1 | 2016 | 413 | 0.030 |
Why?
|
Radiography, Thoracic | 2 | 2017 | 1302 | 0.030 |
Why?
|
Computer Communication Networks | 1 | 1996 | 293 | 0.030 |
Why?
|
Myocardial Infarction | 2 | 2014 | 11461 | 0.030 |
Why?
|
Diaphragm | 1 | 2016 | 351 | 0.030 |
Why?
|
Pregnancy | 2 | 2016 | 29876 | 0.030 |
Why?
|
Ethics, Medical | 1 | 2019 | 783 | 0.030 |
Why?
|
Hospitals, Public | 1 | 2016 | 202 | 0.030 |
Why?
|
Germany | 1 | 2016 | 875 | 0.030 |
Why?
|
Enzyme Activation | 1 | 2000 | 3597 | 0.030 |
Why?
|
Coronary Artery Disease | 1 | 2014 | 6403 | 0.030 |
Why?
|
Lifting | 1 | 2014 | 55 | 0.030 |
Why?
|
Administration, Inhalation | 1 | 2017 | 1157 | 0.030 |
Why?
|
Ventricular Outflow Obstruction | 1 | 1996 | 261 | 0.030 |
Why?
|
Quality Improvement | 2 | 2019 | 3801 | 0.030 |
Why?
|
Hydroxymethylglutaryl-CoA Reductase Inhibitors | 1 | 2009 | 3245 | 0.030 |
Why?
|
Early Diagnosis | 2 | 2010 | 1186 | 0.030 |
Why?
|
Medical Staff, Hospital | 1 | 2018 | 601 | 0.030 |
Why?
|
Consensus Development Conferences as Topic | 1 | 2014 | 168 | 0.030 |
Why?
|
Anticoagulants | 1 | 2009 | 4812 | 0.030 |
Why?
|
Intra-Aortic Balloon Pumping | 1 | 2015 | 223 | 0.030 |
Why?
|
Risk | 2 | 2016 | 9610 | 0.030 |
Why?
|
Models, Biological | 1 | 2009 | 9469 | 0.030 |
Why?
|
Peer Review, Research | 1 | 1996 | 340 | 0.030 |
Why?
|
Geriatric Assessment | 1 | 2021 | 1410 | 0.030 |
Why?
|
Causality | 2 | 2011 | 1242 | 0.030 |
Why?
|
Wounds, Nonpenetrating | 1 | 1999 | 807 | 0.030 |
Why?
|
Neurosurgical Procedures | 1 | 2004 | 2072 | 0.030 |
Why?
|
Receptors, N-Methyl-D-Aspartate | 1 | 1998 | 895 | 0.030 |
Why?
|
Quality Control | 1 | 2015 | 832 | 0.030 |
Why?
|
Single-Blind Method | 1 | 2016 | 1574 | 0.030 |
Why?
|
Midazolam | 1 | 2014 | 266 | 0.030 |
Why?
|
Pleura | 1 | 2014 | 245 | 0.030 |
Why?
|
Oscillometry | 1 | 2013 | 150 | 0.030 |
Why?
|
Proportional Hazards Models | 3 | 2015 | 12463 | 0.030 |
Why?
|
Muscle Strength | 1 | 2017 | 624 | 0.030 |
Why?
|
Ketamine | 1 | 1998 | 519 | 0.030 |
Why?
|
Echocardiography, Doppler | 1 | 1996 | 897 | 0.030 |
Why?
|
Mice | 2 | 2016 | 81533 | 0.020 |
Why?
|
Automation | 1 | 2014 | 586 | 0.020 |
Why?
|
Obesity | 1 | 2014 | 12947 | 0.020 |
Why?
|
Blood-Brain Barrier | 1 | 1998 | 1027 | 0.020 |
Why?
|
Neuroprotective Agents | 1 | 1998 | 957 | 0.020 |
Why?
|
Faculty | 1 | 2014 | 384 | 0.020 |
Why?
|
Tomography, X-Ray Computed | 3 | 2022 | 20571 | 0.020 |
Why?
|
Drug Resistance | 1 | 2017 | 1596 | 0.020 |
Why?
|
Focus Groups | 1 | 2016 | 1413 | 0.020 |
Why?
|
Catheters | 1 | 2014 | 427 | 0.020 |
Why?
|
Curriculum | 1 | 2024 | 3743 | 0.020 |
Why?
|
Analgesics, Opioid | 2 | 2019 | 3808 | 0.020 |
Why?
|
Databases, Factual | 2 | 2017 | 7967 | 0.020 |
Why?
|
Policy Making | 1 | 2014 | 542 | 0.020 |
Why?
|
Disease Models, Animal | 3 | 2015 | 18253 | 0.020 |
Why?
|
Attitude to Health | 1 | 2019 | 2025 | 0.020 |
Why?
|
Drug Administration Schedule | 1 | 2018 | 4853 | 0.020 |
Why?
|
Sulfonamides | 1 | 2000 | 1978 | 0.020 |
Why?
|
Minnesota | 1 | 2010 | 338 | 0.020 |
Why?
|
Morphine | 1 | 2014 | 657 | 0.020 |
Why?
|
Myocardial Ischemia | 1 | 2000 | 2113 | 0.020 |
Why?
|
Radiography | 2 | 2016 | 6965 | 0.020 |
Why?
|
Brain | 4 | 1999 | 27120 | 0.020 |
Why?
|
Enzyme-Linked Immunosorbent Assay | 1 | 2016 | 3810 | 0.020 |
Why?
|
Confidence Intervals | 1 | 2014 | 2927 | 0.020 |
Why?
|
Injections, Intraperitoneal | 2 | 2000 | 413 | 0.020 |
Why?
|
Pulmonary Embolism | 1 | 2001 | 2567 | 0.020 |
Why?
|
Calcium | 2 | 1998 | 5722 | 0.020 |
Why?
|
Angiopoietin-1 | 1 | 2008 | 122 | 0.020 |
Why?
|
Physicians | 1 | 2006 | 4591 | 0.020 |
Why?
|
Receptor, TIE-2 | 1 | 2008 | 176 | 0.020 |
Why?
|
Observer Variation | 1 | 2014 | 2606 | 0.020 |
Why?
|
Kinetics | 1 | 2015 | 6374 | 0.020 |
Why?
|
Brain Ischemia | 2 | 1998 | 3049 | 0.020 |
Why?
|
Patient Participation | 1 | 2016 | 1445 | 0.020 |
Why?
|
Reactive Oxygen Species | 1 | 2015 | 2141 | 0.020 |
Why?
|
Combined Modality Therapy | 1 | 2019 | 8528 | 0.020 |
Why?
|
Gestational Age | 1 | 2016 | 3577 | 0.020 |
Why?
|
Emergencies | 1 | 2013 | 1217 | 0.020 |
Why?
|
History, 20th Century | 1 | 2014 | 2767 | 0.020 |
Why?
|
Mice, Inbred BALB C | 1 | 2015 | 6214 | 0.020 |
Why?
|
Referral and Consultation | 1 | 2019 | 3600 | 0.020 |
Why?
|
Ventricular Pressure | 1 | 2007 | 210 | 0.020 |
Why?
|
Qualitative Research | 1 | 2016 | 3023 | 0.020 |
Why?
|
Models, Theoretical | 1 | 2018 | 3575 | 0.020 |
Why?
|
Body Mass Index | 2 | 2014 | 12954 | 0.020 |
Why?
|
Ventricular Function, Left | 1 | 2018 | 3879 | 0.020 |
Why?
|
Pregnancy Outcome | 1 | 2016 | 2922 | 0.020 |
Why?
|
Bone Marrow | 1 | 2015 | 2911 | 0.020 |
Why?
|
Urea | 1 | 2007 | 443 | 0.020 |
Why?
|
Physician-Patient Relations | 1 | 2018 | 3249 | 0.020 |
Why?
|
Automobiles | 1 | 2005 | 111 | 0.010 |
Why?
|
Necrosis | 2 | 1999 | 1611 | 0.010 |
Why?
|
Infant | 2 | 2017 | 36192 | 0.010 |
Why?
|
Poverty | 1 | 2016 | 2698 | 0.010 |
Why?
|
Child | 1 | 2012 | 80156 | 0.010 |
Why?
|
Hypothalamus | 2 | 2000 | 999 | 0.010 |
Why?
|
Immunoassay | 1 | 2007 | 745 | 0.010 |
Why?
|
Ambulatory Surgical Procedures | 1 | 2008 | 464 | 0.010 |
Why?
|
Internationality | 1 | 2008 | 1001 | 0.010 |
Why?
|
Ventricular Function, Right | 1 | 2007 | 617 | 0.010 |
Why?
|
Disease Management | 1 | 2013 | 2508 | 0.010 |
Why?
|
Neutrophils | 1 | 2015 | 3767 | 0.010 |
Why?
|
Perfusion | 1 | 2007 | 1373 | 0.010 |
Why?
|
Prevalence | 1 | 2019 | 15732 | 0.010 |
Why?
|
Ultrasonography | 1 | 2016 | 5972 | 0.010 |
Why?
|
Body Weight | 1 | 2013 | 4618 | 0.010 |
Why?
|
Benchmarking | 1 | 2008 | 1045 | 0.010 |
Why?
|
Acute Disease | 1 | 2012 | 7237 | 0.010 |
Why?
|
Health Policy | 1 | 2014 | 2684 | 0.010 |
Why?
|
Paracentesis | 1 | 2001 | 98 | 0.010 |
Why?
|
Health Status | 1 | 2013 | 4077 | 0.010 |
Why?
|
Halothane | 1 | 2000 | 200 | 0.010 |
Why?
|
Morbidity | 1 | 2005 | 1750 | 0.010 |
Why?
|
Hemodilution | 1 | 1999 | 120 | 0.010 |
Why?
|
Adrenergic beta-Antagonists | 1 | 2005 | 1241 | 0.010 |
Why?
|
Emergency Medicine | 1 | 2007 | 1198 | 0.010 |
Why?
|
Cyclooxygenase 2 Inhibitors | 1 | 2000 | 321 | 0.010 |
Why?
|
Socioeconomic Factors | 1 | 2011 | 7827 | 0.010 |
Why?
|
Cyclooxygenase 2 | 1 | 2000 | 597 | 0.010 |
Why?
|
Chronic Disease | 1 | 2012 | 9319 | 0.010 |
Why?
|
Phosphorylation | 1 | 2008 | 8321 | 0.010 |
Why?
|
Internship and Residency | 1 | 1996 | 5882 | 0.010 |
Why?
|
Magnesium | 1 | 1998 | 804 | 0.010 |
Why?
|
Injury Severity Score | 1 | 1998 | 1045 | 0.010 |
Why?
|
Child, Preschool | 1 | 2017 | 42230 | 0.010 |
Why?
|
Diabetes Mellitus | 1 | 2011 | 5841 | 0.010 |
Why?
|
Homeostasis | 1 | 1998 | 3323 | 0.000 |
Why?
|
Image Processing, Computer-Assisted | 1 | 2002 | 9002 | 0.000 |
Why?
|
Ovarian Neoplasms | 1 | 2001 | 4878 | 0.000 |
Why?
|
Cerebral Cortex | 1 | 2000 | 5779 | 0.000 |
Why?
|
Apoptosis | 1 | 1998 | 9489 | 0.000 |
Why?
|
Signal Transduction | 1 | 1998 | 23447 | 0.000 |
Why?
|